News

Legal Updates on Semler Scientific and Stockholder Rights

Legal Updates on Semler Scientific and Stockholder Rights

Important Legal Updates for Semler Scientific, Inc.

In recent developments, Levi & Korsinsky, LLP, a prominent law firm known for representing shareholders, has alerted investors of an important class action lawsuit involving Semler Scientific, Inc. (NASDAQ: SMLR). This lawsuit is designed to safeguard the interests of shareholders who may have faced losses due to alleged fraudulent activities within the company.

Understanding the Class Action Lawsuit

The class action lawsuit aims to recuperate financial losses for those affected by supposed securities fraud that transpired between March 10, 2021, and April 15, 2025. Investors are encouraged to understand their rights and step forward if they believe they have been wronged.

Details on the Allegations

According to the filed complaint, the allegations specify that key company officials failed to disclose a significant investigation by the United States Department of Justice concerning possible violations of the False Claims Act. Such omissions are claimed to have misled the public and investors regarding the company's true state of operations.

Timeline and Important Dates

For investors who feel impacted, it is critical to note that they have until October 28, 2025, to petition the court to be appointed as lead plaintiff. This designation may influence the recovery process but is not a requirement for sharing in any future recoveries.

No Upfront Costs for Participants

Those who join this class action suit can do so without incurring any out-of-pocket fees or costs. This means that participating in the lawsuit to potentially recover losses can be done without financial burden.

The Role of Levi & Korsinsky

Levi & Korsinsky has a long history of supporting aggrieved shareholders and has accumulated a considerable record of success in high-stakes securities litigation. Over the past 20 years, they have recovered hundreds of millions of dollars for clients, thus establishing a reputation as a formidable ally for investors in the complexities of securities issues.

Contact and Support Information

For further inquiries, investors may reach out to Joseph E. Levi, Esq. through email or phone. The office is located at 33 Whitehall Street, 17th Floor, New York, NY 10004. Levi & Korsinsky also encourages any interested shareholders to get in touch, emphasizing that there is no cost to consult with their team.

Frequently Asked Questions

What is the lawsuit about?

The lawsuit concerns allegations of securities fraud against Semler Scientific, Inc., aiming to recover losses for investors.

Who can join the class action?

Any investor who experienced financial losses in Semler Scientific during the relevant time frame can join.

What actions must be taken by October 28, 2025?

Investors must request to be appointed as lead plaintiffs by this date to have a central role in the proceedings.

Are there costs associated with joining?

No, class members can participate without paying any costs or fees upfront.

How can I contact Levi & Korsinsky?

Investors can email jlevi@levikorsinsky.com or call (212) 363-7500 for assistance and inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gold Prices Climb; Miners Stick to Guidance Amid Stress

Updated Category News Views 110

Wham, pow! Gold's climbing up to the skies again. As if the shiny stuff needed more fanfare, there it is, breaking above $4,000 an ounce. Remember when it couldn't hold a candle to $1,500? Now the December gold futures are planting themselves firmly at $4,124.10. That's a healthy leap from Friday's close by $49.20. How about that for a head-turner? Miners Holding the Line...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 70

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
WSIB Slashes Registration Time with Guidewire Boost

Updated Category News Views 63

Quick Fix: Streamlining Ontario's Employer Registration Alright, let's cut through the formalities and tell it like it is: Ontario's Workplace Safety and Insurance Board (WSIB) isn't messing around anymore. They've yanked their antiquated paper-laden process into the digital age, slicing the employer registration wait down from an agonizing eight to ten-day ordeal to a...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 42

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Delta Marks 19 Years at COP With Bold New Initiatives

Updated Category News Views 150

Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...

Continue Reading
Empyrean Eases Public Sector Benefits with OMNIA Deal

Updated Category News Views 126

In a world where bureaucratic red tape often chokes efficiency, Empyrean throws a lifeline to public sector bodies. They've nabbed a cooperative purchasing contract with OMNIA Partners, dialing down the procurement guts to make benefits administration easier for government and education folks. Streamlining Public Sector Procurement Public sector organizations ain't...

Continue Reading
Smart Cooling Accessory: A Game Changer for AC Units?

Updated Category News Views 76

New Kid on the Block: The Smart Cooling Game They say the devil's in the details, and this one’s got all the right tweaks. Picture this — a compressor-based air conditioning system beefing up with a savvy accessory that promises to give your condenser coil some extra muscle. That's right, we've got ourselves a new contender in the cooling corner: THE CSC UNIT. It's...

Continue Reading
QuidelOrtho Shares Plunge 14% Amid Legal Scrutiny

Updated Category News Views 25

QuidelOrtho's Rocky Road Oh, it's been a roller coaster for QuidelOrtho's stock. Lately, it’s like holding onto a greased pole in a thunderstorm. November 9th, 2026, wasn't a friend to QDEL shareholders; the stock's down about 14%, and now some legal eagles want to know if there's more to the story. When you go poking around in the financials and spotlight that nasty...

Continue Reading
Children's Institute Gala Raises $4M: A Night to Remember

Updated Category News Views 82

Breaking Records and Honoring Legends You know, sometimes there's more to the world than stocks and ticker tapes. Over in Los Angeles, the Children's Institute pulled off a real spectacle with their Annual Cape & Gown Gala, drawing in more than 600 folks and raking in a whopping $4 million. That's right, four million clams in one evening—a record-breaker for them. When...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 146

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading

Top 5 Most Recently Viewed Articles

Oakworth Capital Inc. Delivers Consistent Annual Dividend Growth

Updated Category News Views 149

Oakworth Capital Inc. Declares Annual Dividend The Board of Directors of Oakworth Capital Inc. met recently and announced a notable achievement: an annual dividend of $0.45 per common share. This marks the 10th consecutive year that the company has provided a cash dividend to its shareholders, showcasing their commitment to returning value to investors. Amazing...

Continue Reading
SELLAS Life Sciences Group Targets Major Milestones Ahead

Updated Category News Views 204

SELLAS Life Sciences Group Moves Forward with Cancer Research SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is taking significant steps in advancing its cancer therapies, aiming for pivotal milestones that are expected in the coming years. With a market capitalization of approximately $74 million, this late-stage clinical biopharmaceutical company is on the verge of...

Continue Reading
Fortran Corporation's Strategic Move to Acquire Intech Systems

Updated Category News Views 152

Fortran Corporation Makes Significant Acquisition Move Fortran Corporation (OTC: FRTN) has recently signed a Letter of Intent (LOI) that heralds a promising new chapter for the company. This LOI is aimed at acquiring Intech Systems of South Carolina, Inc., a significant player in telecommunication sales and services. Impacts of the Acquisition The company’s President,...

Continue Reading
Action Alert: Novo Nordisk (NYSE: NVO) Investors Required to Act Soon

Updated Category News Views 164

Urgent Notice for Novo Nordisk (NYSE: NVO) Investors As the situation develops, investors in Novo Nordisk A/S, a renowned global pharmaceutical company, are advised to stay informed about a potential securities fraud class action. This comes in light of recent legal challenges aimed at the company, and those holding Novo securities need to take notice. Investor Action...

Continue Reading
Galan Lithium Secures A$20 Million Commitment from Clean Elements

Updated Category News Views 303

Galan Lithium Limited Announces Strategic A$20 Million Placement Galan Lithium Limited (ASX:GLN) is excited to share that it has successfully obtained a binding commitment for a significant A$20 million placement at A$0.11 per share. This represents a remarkable 21% premium over the most recent closing price of A$0.091, showcasing the confidence investors have in the...

Continue Reading